Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Orphenadrine 50mg tablets |
| BNF code | 0409020N0AAAMAM |
| Virtual Therapeutic Moiety | Orphenadrine |
| Date identifier became valid | 26 May 2021 |
| Previous product identifier | 323234000 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products Available |
| Non-availability status date | 2 Jul 2018 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Orphenadrine hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Lysantin 50mg tablets (Imported (Denmark)) | |
| Orphenadrine 50mg tablets (Part VIIID Drug Tariff Special Order) | |
| Virtual Medicinal Product Packs | |
| Orphenadrine 50mg tablets 100 tablet | |
| Orphenadrine 50mg tablets 1 tablet | |
| Orphenadrine 50mg tablets 250 tablet | |
| Orphenadrine 50mg tablets 50 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_12.0.0_20251201000001, imported on 2nd December 2025 at 05:00:34.